āagmanLoginNot investment advice. Data and computed figures, for information only.
Medplus Health Services Ltd
₹611.95
−₹0.85 (−0.14%)
NSE · 16 Oct 2026, close
Market Cap
₹7,512 Cr
CMP
₹611.95
52-wk High / Low
₹1,022 / 609
P/E
35.7
P/B
3.8
Book Value
₹165.0
Div Yield
0.00%
ROCE
13.0%
ROE
11.6%
Face Value
₹2
D/E
0.72
Price−21.3% over 1Y
āagman read
Computed by āagmanPiotroski F-Score
6
/ 9
6 of 9 F-score tests passed
Graham Number
₹261
√(22.5 × EPS × book value per share)
ROIC
7.6%
vs 7.6% sector median
Cash flow to profit
2.25
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−142
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
11.6%
ROE × earnings retention ratio
ROE stability
2.9
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −0.02FII −2.95DII +4.07
Latest quarter vs the previous one
Cash-accrual divergence
−7.6%
of assets
Low = accruals track cash flow
Strengths
+FII holding rose by 8.1pp over the last year
+PE of 35.7x is below the sector median of 41.4x
Watch-outs
−Borrowings are up 538.6% since FY2016 (223 to 1424)
−Price trades below its 200-day moving average (0.8x)
−Price is 40.1% below its 52-week high
−Promoter holding fell by 0.2pp over the last year
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,284 | 1,409 | 1,441 | 1,490 | 1,489 | 1,576 | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 |
| Expenses | 1,213 | 1,324 | 1,350 | 1,385 | 1,395 | 1,452 | 1,429 | 1,373 | 1,412 | 1,530 | 1,648 | 1,695 | 1,746 |
| Operating Profit | 71 | 85 | 92 | 106 | 94 | 124 | 133 | 136 | 131 | 149 | 159 | 169 | 133 |
| OPM % | 5.5% | 6.0% | 6.4% | 7.1% | 6.3% | 7.9% | 8.5% | 9.0% | 8.5% | 8.9% | 8.8% | 9.1% | 7.1% |
| Other Income | 9 | 10 | 10 | 10 | 9 | 12 | 13 | 16 | 15 | 17 | 18 | 21 | 20 |
| Interest | 23 | 24 | 24 | 25 | 25 | 25 | 26 | 27 | 27 | 29 | 31 | 33 | 33 |
| Depreciation | 52 | 55 | 57 | 59 | 60 | 63 | 62 | 64 | 66 | 69 | 73 | 76 | 78 |
| Profit before tax | 5 | 16 | 20 | 32 | 18 | 48 | 57 | 61 | 53 | 69 | 73 | 80 | 42 |
| Net Profit | 4 | 15 | 14 | 34 | 14 | 39 | 46 | 51 | 42 | 56 | 58 | 64 | 33 |
| EPS (₹) | 0.32 | 1.22 | 1.15 | 2.79 | 1.20 | 3.24 | 3.83 | 4.29 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,368 | 1,733 | 2,011 | 2,131 | 2,273 | 2,871 | 3,069 | 3,779 | 4,558 | 5,625 | 6,136 | 6,892 | 7,229 |
| Expenses | 1,336 | 1,696 | 1,940 | 2,073 | 2,153 | 2,737 | 2,852 | 3,507 | 4,292 | 5,270 | 5,648 | 6,284 | 6,620 |
| Operating Profit | 32 | 37 | 71 | 58 | 120 | 134 | 217 | 273 | 266 | 355 | 488 | 608 | 610 |
| OPM % | 2.3% | 2.1% | 3.5% | 2.7% | 5.3% | 4.7% | 7.1% | 7.2% | 5.8% | 6.3% | 8.0% | 8.8% | 8.4% |
| Other Income | 4 | 8 | 7 | 8 | 11 | 17 | 21 | 31 | 46 | 40 | 48 | 71 | 76 |
| Interest | 14 | 17 | 19 | 28 | 50 | 47 | 55 | 66 | 83 | 96 | 103 | 120 | 126 |
| Depreciation | 9 | 10 | 11 | 12 | 59 | 75 | 88 | 119 | 182 | 224 | 250 | 283 | 295 |
| Profit before tax | 14 | 19 | 48 | 26 | 23 | 29 | 95 | 118 | 47 | 73 | 183 | 275 | 264 |
| Net Profit | 7 | 9 | 29 | 42 | 12 | 2 | 63 | 95 | 50 | 66 | 150 | 220 | 210 |
| EPS (₹) | 419.34 | 508.71 | 1,620.57 | 2,080.06 | 585.46 | 107.02 | 1,393.11 | 8.03 | 4.17 | 5.48 | 12.56 | 18.30 | 17.54 |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 24 | 24 | 24 | 24 | — |
| Reserves | 141 | 137 | 148 | 303 | 291 | 528 | 730 | 1,394 | 1,467 | 1,554 | 1,717 | 1,951 | — |
| Borrowings | 170 | 223 | 204 | 162 | 429 | 477 | 590 | 815 | 900 | 1,010 | 1,120 | 1,424 | — |
| Other Liabilities | 126 | 149 | 183 | 179 | 239 | 344 | 245 | 361 | 406 | 417 | 500 | 533 | — |
| Total Liabilities | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 | — |
| Fixed Assets | 67 | 77 | 81 | 83 | 377 | 419 | 517 | 799 | 1,138 | 1,242 | 1,296 | 1,595 | — |
| CWIP | 3 | 3 | 2 | 1 | 1 | 5 | 6 | 20 | 25 | 11 | 16 | 32 | — |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Other Assets | 368 | 429 | 453 | 560 | 580 | 924 | 1,043 | 1,775 | 1,633 | 1,752 | 2,047 | 2,306 | — |
| Total Assets | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 | — |
Cash Flows
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | −19 | −17 | 34 | 32 | 147 | −7 | 3 | 170 | 90 | 144 | 540 | 496 |
| Cash from Investing Activity | −16 | −32 | −15 | −18 | −19 | −28 | −35 | −703 | 429 | −83 | −318 | −128 |
| Cash from Financing Activity | 67 | 35 | −29 | −1 | −83 | 90 | −6 | 440 | −170 | −198 | −228 | −256 |
| Net Cash Flow | 32 | −15 | −10 | 14 | 45 | 56 | −37 | −93 | 350 | −137 | −5 | 112 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 11.0 | 19.0 | 13.0 | 12.0 | 9.0 | 13.0 | 10.0 | 5.0 | 7.0 | 10.0 | 13.0 |
| ROE % | — | — | — | — | — | — | — | — | — | — | — | 11.6 |
| EPS (₹) | 419.34 | 508.71 | 1,620.57 | 2,080.06 | 585.46 | 107.02 | 1,393.11 | 8.03 | 4.17 | 5.48 | 12.56 | 18.30 |
| Book Value (₹) | — | — | — | — | — | — | — | — | — | — | — | 165.0 |
| Face Value (₹) | — | — | — | — | — | — | — | — | — | — | — | 2 |
| P/E | — | — | — | — | — | — | — | — | — | — | — | 35.7 |
| Div Yield % | — | — | — | — | — | — | — | — | — | — | — | 0.00 |
| NPM % | 0.5 | 0.5 | 1.4 | 2.0 | 0.5 | 0.1 | 2.0 | 2.5 | 1.1 | 1.2 | 2.4 | 3.2 |
| OPM % | 2.4 | 2.1 | 3.5 | 2.7 | 5.0 | 4.7 | 7.0 | 7.0 | 6.0 | 6.0 | 8.0 | 9.0 |
| D/E | 1.20 | 1.63 | 1.38 | 0.53 | 1.47 | 0.90 | 0.81 | 0.57 | 0.60 | 0.64 | 0.64 | 0.72 |
| P/B | — | — | — | — | — | — | — | — | — | — | — | 3.8 |
Growth
Compounded sales growth
10 years+15.0%
5 years+18.0%
3 years+15.0%
TTM+17.0%
Compounded profit growth
10 years+37.0%
5 years+28.0%
3 years+66.0%
TTM+18.0%
Stock price CAGR
3 years−6.0%
Last year−20.0%
Return on equity
10 years8.0%
5 years7.0%
3 years8.0%
Last year12.0%
Documents
Announcements
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Corporate actions
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman